Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human DLL1 ELISA Kit (AC2481)
Cat.#: ASET-1070
Specifications
Description Human DLL1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human DLL1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 3.12 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 75-1200 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2501 Human Ferritin Heavy Chain ELISA Kit (AC3912) Quantitative inquiry ASET-1962 Mouse Renalase ELISA Kit (AC3373) Quantitative inquiry ASET-1027 Mouse Gpi ELISA Kit (AC2438) Quantitative inquiry ASET-2338 Oxytocin ELISA Kit (AC3749) Quantitative inquiry ASET-1903 Human DUOX1 ELISA Kit (AC3314) Quantitative inquiry ASET-1452 Mouse Cannabinoid Receptor II ELISA Kit (AC2863) Quantitative inquiry ASET-1287 Rat Creatine Kinase B Type ELISA Kit (AC2698) Quantitative inquiry ASET-1539 Rabbit Estradiol ELISA Kit (AC2950) Quantitative inquiry ASET-1981 Human NRG3 ELISA Kit (AC3392) Quantitative inquiry ASET-1194 Human VAMP2 ELISA Kit (AC2605) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket